Is FTRBX or JNJ a better dividend investment in 2026?

FTRBX currently yields 4.56% with a 5% 5-year dividend growth rate. JNJ yields 3.36% with 5.8% growth. The better choice depends on your goal: FTRBX offers higher current income.

What is the dividend yield difference between FTRBX and JNJ?

FTRBX has a forward dividend yield of 4.56% ($0.43/share annually). JNJ yields 3.36% ($4.96/share annually). The yield gap is 1.20 percentage points.

Home › Compare › FTRBX vs JNJ

FTRBX vs JNJ: Dividend Comparison 2026

FTRBX yields 4.56% · JNJ yields 3.36%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 FTRBX wins by $6.9K in total portfolio value

INVESTMENT

TIME HORIZON10 years

FTRBX

● Live price

4.56%

Share price

$9.45

Annual div

$0.43

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$26.9K

Annual income

$610.11

Full FTRBX calculator →

JNJ

Johnson & Johnson

● Live price

3.36%

Share price

$147.50

Annual div

$4.96

5Y div CAGR

5.8%

Payout ratio

55%

After 10 yrs · $10,000 · DRIP

Portfolio value

$20.0K

Annual income

$827.78

Full JNJ calculator →

Portfolio growth — FTRBX vs JNJ

📍 FTRBX pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	FTRBX	JNJ
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, FTRBX + JNJ cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

FTRBX pays

JNJ pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

FTRBX

Annual income on $10K today (after 15% tax)

$387.29/yr

After 10yr DRIP, annual income (after tax)

$518.59/yr

JNJ

Annual income on $10K today (after 15% tax)

$285.83/yr

After 10yr DRIP, annual income (after tax)

$703.61/yr

At 15% tax rate, JNJ beats the other by $185.02/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of FTRBX + JNJ for your $10,000?

FTRBX: 50%JNJ: 50%

100% JNJ50/50100% FTRBX

Portfolio after 10yr

$23.5K

Annual income

$718.94/yr

Blended yield

3.06%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

FTRBX

No analyst data

JNJ

Analyst Ratings

Buy

Hold

Sell

Consensus: Buy

Price Target

$228.73

+55.1% upside vs current

Range: $190.00 — $265.00

Altman Z

5.2

Piotroski

4/9

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

FTRBX buys

JNJ buys

No recent congressional trades found for FTRBX or JNJ in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricFTRBXJNJ

Forward yield	4.56% ✓	3.36%
Annual dividend / share	$0.43	$4.96 ✓
Payout ratio	50% ✓	55%
1-year div growth	0%	4.2% ✓
5-year div CAGR	0%	5.8% ✓
Portfolio after 10y	$26.9K ✓	$20.0K
Annual income after 10y	$610.11	$827.78 ✓
Total dividends collected	$5.4K	$5.6K ✓
Payment frequency	quarterly	quarterly
Sector	Stock	Healthcare

Year-by-year: FTRBX vs JNJ ($10,000, DRIP)

Year	FTRBX Portfolio	FTRBX Income/yr	JNJ Portfolio	JNJ Income/yr	Gap
1← crossover	$11,156	$455.64	$10,676	$355.77	+$480.00 → FTRBX
2	$12,412	$475.04	$11,407	$389.39	+$1.0K → FTRBX
3	$13,774	$493.95	$12,198	$426.53	+$1.6K → FTRBX
4	$15,251	$512.32	$13,056	$467.62	+$2.2K → FTRBX
5	$16,849	$530.13	$13,987	$513.12	+$2.9K → FTRBX
6	$18,575	$547.35	$14,998	$563.56	+$3.6K → FTRBX
7	$20,440	$563.97	$16,098	$619.52	+$4.3K → FTRBX
8	$22,450	$579.97	$17,295	$681.69	+$5.2K → FTRBX
9	$24,617	$595.35	$18,599	$750.82	+$6.0K → FTRBX
10	$26,950	$610.11	$20,022	$827.78	+$6.9K → FTRBX

FTRBX vs JNJ: Complete Analysis 2026

FTRBX — Stock

The fund pursues its investment objective by investing primarily in U.S. dollar denominated, investment-grade, fixed-income securities. In addition, it may invest in high-yield, non-U.S. dollar denominated, and emerging market fixed- income securities. The amount of any unhedged non-U.S. dollar denominated fixed-income securities and foreign currencies in the fund's portfolio will normally not exceed 10% of the fund's total assets. The maximum amount that the fund may invest in non-U.S. dollar denominated fixed-income securities and foreign currencies is 20% of the fund's total assets.

Full FTRBX Calculator →

JNJ — Healthcare

Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.

Full JNJ Calculator →

📬

Get this FTRBX vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

FTRBX vs SCHD FTRBX vs JEPI FTRBX vs O FTRBX vs KO FTRBX vs MAIN FTRBX vs ABBV FTRBX vs MRK FTRBX vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.